Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$293M |
| 2 |
Tyson Foods
TSN
|
+$236M |
| 3 |
JPMorgan Chase
JPM
|
+$236M |
| 4 |
Archer Daniels Midland
ADM
|
+$211M |
| 5 |
LTRPA
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$573M |
| 2 |
Apple
AAPL
|
+$465M |
| 3 |
Invesco
IVZ
|
+$235M |
| 4 |
Visa
V
|
+$219M |
| 5 |
Citigroup
C
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.67% |
| 2 | Consumer Discretionary | 7.23% |
| 3 | Energy | 7.11% |
| 4 | Healthcare | 5.3% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Interactive Brokers
IBKR
$39.8B
| $304K | ﹤0.01% |
48,672
-118,572
| -71% | -$705K |
|
5127
Cytokinetics
CYTK
$10.4B
| $303K | ﹤0.01% |
86,098
+62,843
| +270% | +$264K |
|
5128
Incyte
INCY
$24.4B
| $303K | ﹤0.01% |
6,183
-524,068
| -99% | -$26.3M |
|
5129
CALL
Novavax
NVAX
$1.31B
| $303K | ﹤0.01% |
3,630
-400
| -10% | -$36.2K |
|
5130
Golub Capital BDC
GBDC
$3.42B
| $302K | ﹤0.01% |
19,319
-900
| -4% | -$15K |
|
5131
Gogo Inc
GOGO
$493M
| $302K | ﹤0.01% |
17,912
+4,294
| +32% | +$73.3K |
|
5132
CALL
Hexcel
HXL
$7.82B
| $302K | ﹤0.01% |
7,600
+3,300
| +77% | +$130K |
|
|
SCMP
5133
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $302K | ﹤0.01% |
46,528
-19,169
| -29% | -$127K |
|
|
CVC
5134
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $302K | ﹤0.01% |
17,264
-148,147
| -90% | -$2.74M |
|
5135
Option Care Health
OPCH
$3.56B
| $301K | ﹤0.01% |
10,878
-4,521
| -29% | -$140K |
|
|
FMI
5136
DELISTED
Foundation Medicine, Inc.
FMI
| $301K | ﹤0.01% |
+15,860
| New | +$378K |
|
5137
Brookfield Infrastructure Partners
BIP
$18B
| $300K | ﹤0.01% |
19,868
+7,654
| +63% | +$124K |
|
|
RNF
5138
CALL
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
| $300K | ﹤0.01% |
24,100
-5,600
| -19% | -$85.4K |
|
|
EFII
5139
CALL
DELISTED
Electronics for Imaging
EFII
| $300K | ﹤0.01% |
6,800
+5,500
| +423% | +$245K |
|
5140
PUT
Dana Inc
DAN
$3.06B
| $299K | ﹤0.01% |
15,600
+5,800
| +59% | +$132K |
|
5141
Robert Half
RHI
$4.37B
| $299K | ﹤0.01% |
6,102
-714,847
| -99% | -$35.4M |
|
5142
Sanofi
SNY
$104B
| $299K | ﹤0.01% |
+5,300
| New | +$285K |
|
|
ECOM
5143
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $299K | ﹤0.01% |
18,199
-1,555,493
| -99% | -$29.6M |
|
|
ICON
5144
DELISTED
Iconix Brand Group, Inc.
ICON
| $299K | ﹤0.01% |
809
+648
| +402% | +$267K |
|
|
NTK
5145
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $299K | ﹤0.01% |
4,008
+1,142
| +40% | +$94K |
|
|
CFN
5146
CALL
DELISTED
CAREFUSION CORPORATION
CFN
| $299K | ﹤0.01% |
6,600
-1,600
| -20% | -$72.1K |
|
5147
Magna International
MGA
$18.8B
| $298K | ﹤0.01% |
6,274
-40,600
| -87% | -$2.23M |
|
|
IMMU
5148
CALL
DELISTED
Immunomedics Inc
IMMU
| $298K | ﹤0.01% |
80,200
+5,500
| +7% | +$18.6K |
|
5149
PUT
Clean Harbors
CLH
$16.3B
| $297K | ﹤0.01% |
5,500
-2,000
| -27% | -$118K |
|
|
DMC
5150
PUT
Del Monte Corp
DMC
$1.45B
| $297K | ﹤0.01% |
9,300
+9,000
| +3,000% | +$281K |
|
Similar funds
Citadel Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, Citadel Advisors held 8,903 positions worth $95.5B, up 9.4% from $87.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Citadel Advisors deployed $4.75B of net new capital in Q3 2014, opening 941 new positions and adding to 3,966 existing holdings. Its largest new stake was Liberty TripAdvisor Holdings, Inc. Series A: 5,382,881 shares worth $182M.
By sector, the portfolio is most concentrated in Financials at 7.7% of assets, down from 8.1% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $573M trimmed.
- Citadel Advisors's largest Q3 2014 buy was Liberty TripAdvisor Holdings, Inc. Series A: 5,382,881 shares worth $182M.
- Citadel Advisors added most to Invesco QQQ Trust in Q3 2014, an estimated $293M increase.
- Citadel Advisors's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $573M.
- Citadel Advisors fully exited INTERMUNE INC in Q3 2014, selling an estimated $52.7M.
- Citadel Advisors's ten largest holdings make up 16% of its $95.5B portfolio in Q3 2014.
- Citadel Advisors opened 941 new positions and closed 819 in Q3 2014.
- Citadel Advisors's portfolio value rose 9.4% quarter-over-quarter to $95.5B.
Based on Citadel Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.